PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oneness Biotech Company Limited, Taipei, Taiwan.\', \'Microbio (Shanghai) Biotech Company, Shanghai, China.\', \'Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan.\', \'Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.\', \'Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan.\', \'Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.\', \'Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.\', \'Genomics Research Center, Academia Sinica, Taipei, Taiwan.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/emmm.202115298
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 35138028
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
?:title
  • A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35138028>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35138028>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all